XEROX HOLDINGS CORP (XRX) Stock Fundamental Analysis

NASDAQ:XRX • US98421M1062

1.86 USD
-0.11 (-5.58%)
At close: Feb 19, 2026
1.8898 USD
+0.03 (+1.6%)
After Hours: 2/19/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall XRX gets a fundamental rating of 3 out of 10. We evaluated XRX against 36 industry peers in the Technology Hardware, Storage & Peripherals industry. XRX has a bad profitability rating. Also its financial health evaluation is rather negative. XRX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year XRX has reported negative net income.
  • In the past year XRX had a positive cash flow from operations.
  • XRX had negative earnings in each of the past 5 years.
  • Each year in the past 5 years XRX had a positive operating cash flow.
XRX Yearly Net Income VS EBIT VS OCF VS FCFXRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • With a Return On Assets value of -10.62%, XRX perfoms like the industry average, outperforming 47.22% of the companies in the same industry.
  • With a Return On Equity value of -158.51%, XRX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.62%
ROE -158.51%
ROIC N/A
ROA(3y)-8.9%
ROA(5y)-6.63%
ROE(3y)-87.49%
ROE(5y)-56.4%
ROIC(3y)N/A
ROIC(5y)N/A
XRX Yearly ROA, ROE, ROICXRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • XRX has a Gross Margin of 27.07%. This is comparable to the rest of the industry: XRX outperforms 47.22% of its industry peers.
  • XRX's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for XRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.02%
GM growth 5Y-6.26%
XRX Yearly Profit, Operating, Gross MarginsXRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • XRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, XRX has more shares outstanding
  • XRX has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for XRX is higher compared to a year ago.
XRX Yearly Shares OutstandingXRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
XRX Yearly Total Debt VS Total AssetsXRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • XRX has an Altman-Z score of 1.10. This is a bad value and indicates that XRX is not financially healthy and even has some risk of bankruptcy.
  • XRX's Altman-Z score of 1.10 is in line compared to the rest of the industry. XRX outperforms 47.22% of its industry peers.
  • XRX has a debt to FCF ratio of 31.93. This is a negative value and a sign of low solvency as XRX would need 31.93 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 31.93, XRX perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • XRX has a Debt/Equity ratio of 6.10. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of XRX (6.10) is worse than 69.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.1
Debt/FCF 31.93
Altman-Z 1.1
ROIC/WACCN/A
WACC4.23%
XRX Yearly LT Debt VS Equity VS FCFXRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

2.3 Liquidity

  • XRX has a Current Ratio of 1.12. This is a normal value and indicates that XRX is financially healthy and should not expect problems in meeting its short term obligations.
  • XRX has a Current ratio of 1.12. This is in the lower half of the industry: XRX underperforms 61.11% of its industry peers.
  • XRX has a Quick Ratio of 1.12. This is a bad value and indicates that XRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.80, XRX is in line with its industry, outperforming 47.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.8
XRX Yearly Current Assets VS Current LiabilitesXRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • XRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -162.50%.
  • The Revenue has grown by 12.88% in the past year. This is quite good.
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.78%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y-0.4%
Revenue growth 5Y0%
Sales Q2Q%25.73%

3.2 Future

  • The Earnings Per Share is expected to grow by 55.51% on average over the next years. This is a very strong growth
  • XRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y230.29%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
EPS Next 5YN/A
Revenue Next Year8.62%
Revenue Next 2Y2.6%
Revenue Next 3Y1.51%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XRX Yearly Revenue VS EstimatesXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
XRX Yearly EPS VS EstimatesXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • XRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 2.38, which indicates a rather cheap valuation of XRX.
  • Based on the Price/Forward Earnings ratio, XRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of XRX to the average of the S&P500 Index (27.98), we can say XRX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.38
XRX Price Earnings VS Forward Price EarningsXRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • 75.00% of the companies in the same industry are more expensive than XRX, based on the Enterprise Value to EBITDA ratio.
  • 100.00% of the companies in the same industry are more expensive than XRX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.79
EV/EBITDA 15.05
XRX Per share dataXRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • XRX's earnings are expected to grow with 55.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y98.66%
EPS Next 3Y55.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • XRX has a Yearly Dividend Yield of 3.97%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of XRX has falen by -29.01%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • XRX's Dividend Yield is rather good when compared to the industry average which is at 0.65. XRX pays more dividend than 97.22% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.85, XRX pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

  • The dividend of XRX decreases each year by -12.86%.
  • XRX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As XRX did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-12.86%
Div Incr Years0
Div Non Decr Years6
XRX Yearly Dividends per shareXRX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • XRX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-6.81%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
XRX Yearly Income VS Free CF VS DividendXRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

XEROX HOLDINGS CORP

NASDAQ:XRX (2/19/2026, 8:00:02 PM)

After market: 1.8898 +0.03 (+1.6%)

1.86

-0.11 (-5.58%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)01-29
Earnings (Next)04-29
Inst Owners81.7%
Inst Owner Change-23.42%
Ins Owners7.6%
Ins Owner Change-0.04%
Market Cap238.15M
Revenue(TTM)7.02B
Net Income(TTM)-1.04B
Analysts46
Price Target3.91 (110.22%)
Short Float %23.39%
Short Ratio7.95
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly Dividend0.56
Dividend Growth(5Y)-12.86%
DP-6.81%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-69.66%
Min EPS beat(2)-199.01%
Max EPS beat(2)59.69%
EPS beat(4)1
Avg EPS beat(4)-282.35%
Min EPS beat(4)-892.08%
Max EPS beat(4)59.69%
EPS beat(8)1
Avg EPS beat(8)-166.17%
EPS beat(12)4
Avg EPS beat(12)-91.07%
EPS beat(16)6
Avg EPS beat(16)-75.19%
Revenue beat(2)0
Avg Revenue beat(2)-4.64%
Min Revenue beat(2)-4.65%
Max Revenue beat(2)-4.62%
Revenue beat(4)1
Avg Revenue beat(4)-3%
Min Revenue beat(4)-4.65%
Max Revenue beat(4)0.96%
Revenue beat(8)2
Avg Revenue beat(8)-2.85%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)4
Avg Revenue beat(16)-2.06%
PT rev (1m)-48.68%
PT rev (3m)-50.88%
EPS NQ rev (1m)-537.85%
EPS NQ rev (3m)-227.96%
EPS NY rev (1m)-34.76%
EPS NY rev (3m)-45.87%
Revenue NQ rev (1m)-4.59%
Revenue NQ rev (3m)-4.59%
Revenue NY rev (1m)-2.19%
Revenue NY rev (3m)2.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.38
P/S 0.03
P/FCF 1.79
P/OCF 1.06
P/B 0.36
P/tB N/A
EV/EBITDA 15.05
EPS(TTM)-0.6
EYN/A
EPS(NY)0.78
Fwd EY42.03%
FCF(TTM)1.04
FCFY55.85%
OCF(TTM)1.75
OCFY94.06%
SpS54.84
BVpS5.14
TBVpS-19.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.62%
ROE -158.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.07%
FCFM 1.89%
ROA(3y)-8.9%
ROA(5y)-6.63%
ROE(3y)-87.49%
ROE(5y)-56.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.02%
GM growth 5Y-6.26%
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 6.1
Debt/FCF 31.93
Debt/EBITDA 15.15
Cap/Depr 27.49%
Cap/Sales 1.3%
Interest Coverage N/A
Cash Conversion 84.53%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.8
Altman-Z 1.1
F-Score3
WACC4.23%
ROIC/WACCN/A
Cap/Depr(3y)19.43%
Cap/Depr(5y)20.04%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.78%
EPS Next Y230.29%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
EPS Next 5YN/A
Revenue 1Y (TTM)12.88%
Revenue growth 3Y-0.4%
Revenue growth 5Y0%
Sales Q2Q%25.73%
Revenue Next Year8.62%
Revenue Next 2Y2.6%
Revenue Next 3Y1.51%
Revenue Next 5YN/A
EBIT growth 1Y-141.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year146.76%
EBIT Next 3Y29.11%
EBIT Next 5YN/A
FCF growth 1Y-71.52%
FCF growth 3Y9.25%
FCF growth 5Y-22.44%
OCF growth 1Y-56.16%
OCF growth 3Y12.1%
OCF growth 5Y-16.38%

XEROX HOLDINGS CORP / XRX FAQ

What is the ChartMill fundamental rating of XEROX HOLDINGS CORP (XRX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to XRX.


Can you provide the valuation status for XEROX HOLDINGS CORP?

ChartMill assigns a valuation rating of 6 / 10 to XEROX HOLDINGS CORP (XRX). This can be considered as Fairly Valued.


What is the profitability of XRX stock?

XEROX HOLDINGS CORP (XRX) has a profitability rating of 2 / 10.


What is the expected EPS growth for XEROX HOLDINGS CORP (XRX) stock?

The Earnings per Share (EPS) of XEROX HOLDINGS CORP (XRX) is expected to grow by 230.29% in the next year.